Grant: Doctoral Award: Doctoral Foreign Study Award (DFSA)
Direct Payment
$120,000.00
Discovery, characterization, and engineering of novel bacterial immune systems for next-generation genome editing tools
FY 2024-25
Summary
The global rise of multidrug-resistant bacteria has created an urgent demand for new treatments. Phage therapy, which uses viruses to neutralize bacteria, is a promising alternative to antibiotics; however, bacteria often resist phage infection using sophisticated immune systems, complicating the use of phage-based treatments. Despite their clinical importance, most bacterial immune systems remain poorly understood, particularly those prevalent in pathogens. Understanding these immune systems will uncover strategies that bacteria use to resist phage infection, leading to new clinical solutions to combat antibiotic resistance. Furthermore, these insights may reveal innovative molecular tools that can be repurposed to advance human health. My research focuses on a novel broad-spectrum bacterial immune system called Hachiman, which is widespread in pathogenic strains of bacteria including Escherichia coli and Bacillus cereus. Our prior studies have shown that Hachiman triggers antiviral immunity by recognizing host DNA damage, an immune checkpoint conserved across domains of life. This breakthrough has opened new research directions on exploring the unexpected diversity of Hachiman systems and their bioengineering applications. Specifically, I will identify and characterize functionally diverse Hachiman systems found in bacterial pathogens that possess new anti-phage immune mechanisms. Furthermore, I will leverage Hachiman to engineer a minimal genome editing platform enabling improved high-throughput functional analysis of non-coding regions in the human genome, critical for understanding gene regulation and disease. Successful implementation of this proposal will significantly enhance our understanding of bacterial immune systems, paving the way for improved phage therapies and novel molecular tools that can advance human health.
Department
Program
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Recipient
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
516854
Name
Hu Jason J
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Discovery, characterization, and engineering of novel bacterial immune systems for next-generation genome editing tools
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Keyworddelim
Bacterial Immune Systems; Bacteriophage; Biochemistry; Bioengineering; Bioinformatics; Cryo-Electron Microscopy; Phage Therapy; Profile Hidden Markov Models; Structural Biology; Structure-Guided Engineering
Abstract
The global rise of multidrug-resistant bacteria has created an urgent demand for new treatments. Phage therapy, which uses viruses to neutralize bacteria, is a promising alternative to antibiotics; however, bacteria often resist phage infection using sophisticated immune systems, complicating the use of phage-based treatments. Despite their clinical importance, most bacterial immune systems remain poorly understood, particularly those prevalent in pathogens. Understanding these immune systems will uncover strategies that bacteria use to resist phage infection, leading to new clinical solutions to combat antibiotic resistance. Furthermore, these insights may reveal innovative molecular tools that can be repurposed to advance human health. My research focuses on a novel broad-spectrum bacterial immune system called Hachiman, which is widespread in pathogenic strains of bacteria including Escherichia coli and Bacillus cereus. Our prior studies have shown that Hachiman triggers antiviral immunity by recognizing host DNA damage, an immune checkpoint conserved across domains of life. This breakthrough has opened new research directions on exploring the unexpected diversity of Hachiman systems and their bioengineering applications. Specifically, I will identify and characterize functionally diverse Hachiman systems found in bacterial pathogens that possess new anti-phage immune mechanisms. Furthermore, I will leverage Hachiman to engineer a minimal genome editing platform enabling improved high-throughput functional analysis of non-coding regions in the human genome, critical for understanding gene regulation and disease. Successful implementation of this proposal will significantly enhance our understanding of bacterial immune systems, paving the way for improved phage therapies and novel molecular tools that can advance human health.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hu, Jason J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~